Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
- Citation:
- Br J Haematol
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Ajay K Nooka Jonathan L Kaufman Cesar Rodriguez Andrzej Jakubowiak Yvonne Efebera Brandi Reeves Tanya M Wildes Sarah A Holstein Larry D Anderson Ashraf Badros Leyla Shune Ajai Chari Huiling Pei Annelore Cortoos Sharmila Patel Thomas S Lin Peter M Voorhees Saad Z Usmani Paul G Richardson
- Networks:
- Study
- AFT-29 (GRIFFIN)
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- antibody therapy; clinical trials; complete remission; haematological malignancy; minimal residual disease; multiple myeloma.